Age-related macular degeneration is a chronic progressive disease with strong phenotype variability.
1 Focal hyperpigmentation and drusen are among the earliest signs of AMD, eventually progressing to either choroidal neovascularization or geographic atrophy (GA).
2 Geographic atrophy is a distinct entity characterized by slow progression of neurosensory layer atrophy with loss of photoreceptors (PR) and RPE.
3–5 Areas with PR and RPE loss show functional deficiency associated with relative or absolute scotomas, which affect the fovea in late-stage disease and lead to severe and irreversible loss of central visual acuity.
6 Although advanced GA disease affects one third of patients with late AMD,
7,8 it may not be detected clinically until late in the course of the disease as GA typically starts extra-fovealy forming an atrophic island and/or an atrophic ring surrounding the fovea, which preserves central visual acuity.
6,9 This process, termed foveal sparing, is seen by fundus photography and can be delineated using blue light-enhanced fundus autofluorescence (FAF) and recently also by optical coherence tomography (OCT).
6,9–13 The pathophysiological background of this phenotypic foveal sparing is not understood but is speculated to relate to the high density of cones in the central retina, a protective effect of macular pigment and/or a unique choroidal blood supply at the fovea.
14–18 Many strategies are used for imaging GA, each visualizing different pathognomonic features. In fundus photography, enhanced visibility of choroidal vessels is the most obvious sign of a severely atrophic RPE and PR layer.
19 Fundus autofluorescence imaging is based on the autofluorescent features of lipofuscin, which is composed of a mixture of metabolites originating from the visual cycle such as N-retinylidene-N-retinylethanolamine (A2E). Autofluorescence from lipofuscin is a diagnostic marker for retinal aging and an impaired lipid degradation process resulting from incomplete phagocytosis of PR outer segments by the RPE.
20,21 Fundus autofluorescence is used to measure the extent of atrophy, which it identifies as a dark area of hypofluorescence, reflecting a complete absence of fluorophores. Detection of this dark area has been accepted as an endpoint in recent GA progression studies.
18,22,23 By contrast, spectral-domain OCT (SD-OCT), which is predominantly used in therapeutic monitoring of patients with neovascular AMD, serves to determine morphologic features of the neurosensory retina and RPE including subretinal fluid, intraretinal cysts, RPE detachment, and retinal layer integrity based on tissue-specific reflectivity.
24–26 The value of OCT in dry AMD imaging is still being investigated.
27–29 Polarization-sensitive SD-OCT (PS-OCT) is a technological extension of conventional intensity-based OCT and combines the advantages of high-resolution structural imaging and selective identification of the RPE layer.
30 The sensitivity of PS-OCT for RPE is related to the characteristic intracellular pattern of melanosomes in physiological RPE cells modifying the polarization state of backscattered light in a characteristic fashion.
31 The RPE depolarizes the backscattered light (i.e., it scrambles the polarization state of the light) an effect that is measured and quantified by the PS-OCT device in a depth-resolved manner. A reduction of this polarization scrambling effect indicates a loss of RPE cells and/or an alteration related to the progression from early to advanced AMD.
32–35 To date, no prospective clinical study has compared all the systems available for imaging the fovea in GA in a comprehensive way using conventional technologies (infrared imaging [IR], FAF, SD-OCT) and new technologies (PS-OCT). Therefore, the purpose of this study was to determine which imaging modality is most reliable for evaluating foveal integrity or alteration correlated with best-corrected visual acuity (BCVA) measurements. A precise assessment of the fovea, a tiny area of only 1.5 mm,
2,36 which solely determines visual outcome in AMD
6 is of utmost value for monitoring patients in therapeutic studies and future clinical practice, as patients with foveal sparing have the highest risk of vision loss and will benefit most from upcoming treatment options. For this reason, introduction of a retinal imaging strategy that reliably identifies foveal sparing is of great importance.